|
Benchmarking
|
N05.700.150 |
|
|
Problem Behavior
|
F01.145.179.750 |
|
|
Chemokine CCL3
|
D12.644.276.374.200.110.150 |
|
|
Group Purchasing
|
N02.278.216.500.968.679.375 |
|
|
Pharmacology, Clinical
|
H01.158.703.152 |
|
|
Confusion
|
C23.888.592.604.339 |
|
|
Keratoderma, Palmoplantar
|
C17.800.827.475 |
|
|
Acute Febrile Encephalopathy
|
C10.228.140.021 |
|
|
Midline Thalamic Nuclei
|
A08.186.211.200.317.826.701.500 |
|
|
cdc25 Phosphatases
|
D12.644.360.268.100 |
|
|
Chemokine CCL24
|
D23.469.200.110.910 |
|
|
Norpregnadienes
|
D04.210.500.668.651.443 |
|
|
Female Athlete Triad Syndrome
|
F03.400.937.500 |
|
|
Relative Energy Deficiency in Sport
|
F03.400.937 |
|
|
Orthodontists
|
M01.526.485.330.655 |
|
|
Ichthyosis, X-Linked
|
C17.800.827.408 |
|
|
Nigeria
|
Z01.058.290.190.565 |
|
|
Niger
|
Z01.058.290.190.560 |
|
|
Albuterol, Ipratropium Drug Combination
|
D03.605.869.229.400.500 |
|
|
Spinal Cord Stimulation
|
E02.779.468.699 |
|
